Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in Advanced Heart Failure
NCT01065194Phase 3Unknown
- Sponsor
- Medical University of Innsbruck
- Start
- Aug 2009
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of levosimendan in heart failure (HF), sponsored by Medical University of Innsbruck. Status: unknown.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01065194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01065194.